Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...
Utilizing a randomized, open, controlled clinical trial, a study was performed to “evaluate the clinical efficacy and safety of vitamin D” for the prevention of influenza A in infants. Infants were randomized to low-dose or high-dose vitamin D, for four months, with 200 infants in each group. Influenza A was observed in 78 cases of the low-dose group, and 43 cases of the high-dose group. (P=0.0001). In the high-dose vitamin D group, it was observed that “the median durations for fever, cough, and wheezing were shorter.”
In both groups “viral loads showed a downward trend, but were significantly different between groups in the second and third measurements.” Adverse and serious adverse events were reported to be low or very low, and were not significantly different between the two groups. Accordingly, the “incidence of influenza A was significantly lower in the high-dose group, as compared to the low-dose group,” and “the viral loads of influenza A in infants in the high-dose vitamin D group decreased more rapidly [as] compared to those in the low-dose vitamin D” group. Thus, it was concluded that “high dose vitamin D (1,200 IU) is suitable for the prevention of seasonal influenza as evidenced by rapid relief from symptoms, rapid decrease in viral loads, and disease recovery.”
The high dose was also determined to be safe in infants.
Ref.: Zhou J, Du J, Huang L, Wang Y, Shi Y, Lin H. Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial. The Pediatric Infectious Disease Journal. Publish Ahead of Print. DOI: 10.1097/INF.0000000000001890.
Related Biotics Research Products: Bio-D-Mulsion Forte, Bio-ADEK-Mulsion
Submit this form and you'll receive our latest news and updates.
The American Journal of Clinical Nutrition recently published the results of a randomized and placebo-controlled trial e...
Learn moreThe results of a randomized and placebo-controlled trial were recently published in JAMA, evaluating the use of high-dos...
Learn moreThe results of a double-blind randomized and controlled clinical trial evaluating the effect of vitamin D supplementatio...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment